Literature DB >> 22856552

Hantavirus infection among wild small mammals in Vellore, south India.

S Chandy1, R G Ulrich, M Schlegel, R Petraityte, K Sasnauskas, D J Prakash, V Balraj, P Abraham, G Sridharan.   

Abstract

Wild indigenous small mammals including 83 rodents (bandicoot and black rats, and house mice) and a shrew captured from multiple sites in Vellore, south India, were tested for serological and molecular evidence of hantavirus infection. Indirect immunofluorescence assay (IFA) using Hantaan virus (HTNV) antigen indicated hantavirus-reactive antibodies in 16 (19.3%) of 83 rodents (bandicoot and black rats). Western blot (WB) using Thailand virus (THAIV) antigen confirmed hantavirus-reactive antibodies in nine of the 16 HTNV IFA-positive rodents. Reverse transcription polymerase chain reaction (RT-PCR) of lung and kidney tissue of captured mammals resulted in the detection of partial S segment sequence in a bandicoot rat. This study complements our earlier reports on hantavirus epidemiology in south India and documents first laboratory evidence for rodent-associated hantaviruses in south India.
© 2012 Blackwell Verlag GmbH.

Entities:  

Keywords:  Hantavirus; India; bandicoot rat; black rat; house mouse; shrew

Mesh:

Year:  2012        PMID: 22856552     DOI: 10.1111/j.1863-2378.2012.01532.x

Source DB:  PubMed          Journal:  Zoonoses Public Health        ISSN: 1863-1959            Impact factor:   2.702


  2 in total

1.  Anjozorobe hantavirus, a new genetic variant of Thailand virus detected in rodents from Madagascar.

Authors:  Jean-Marc Reynes; Nadia Kaloina Razafindralambo; Vincent Lacoste; Marie-Marie Olive; Tony Andrianaivo Barivelo; Voahangy Soarimalala; Jean-Michel Heraud; Anne Lavergne
Journal:  Vector Borne Zoonotic Dis       Date:  2014-02-27       Impact factor: 2.133

Review 2.  Role of India's wildlife in the emergence and re-emergence of zoonotic pathogens, risk factors and public health implications.

Authors:  B B Singh; A A Gajadhar
Journal:  Acta Trop       Date:  2014-06-28       Impact factor: 3.112

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.